EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD
暂无分享，去创建一个
G. Salles | A. Fischer | É. Oksenhendler | L. Chatenoud | A. Moreau | V. Leblond | B. Belgium | P. Lang | S. Choquet | P. Vandenberghe | S. Fafi-Kremer | O. Hermine | W. Feremans | Y. Lebranchu | G. Socié | R. Herbrecht | F. Morschhauser | A. Ferrant | F. Offner | A. Jaccard | P. Morand | A. Stoppa | T. Lamy | E. Vilmer | M. Peraldi | N. Berriot-Varoqueaux | L. Bergougnoux | J. Garnier